Our (ph)ight against pulmonary arterial hypertension (PAH) is directed at funding research and development of novel diagnostic tools to advance early detection and diagnosis. We are dedicated to educating the gatekeepers of medicine as to the early warning signs of PAH – and providing them with the necessary tools to screen PAH candidates through efficient and less-invasive methods. Our mission is to “rule in” PAH early and efficiently to give those living with this disease every opportunity to live extended and quality lives after diagnosis.
Meredith knows all too well about Pulmonary Arterial Hypertension. It took her mother’s life when she was 12 and reappeared in her own life when she was diagnosed at 34. She is a stay-at-home mom to two boys – ages three and one. Being told she had a disease known as the “silent killer” put the (ph)ight in her to do everything in her power to help others who are currently or will be in her shoes one day.